Periodic Reporting for period 1 - hmqChIP (Highly multiplexed, quantitative epigenetic profiling)

The pharmaceutical industry is burdened by high attrition rates and slow development timelines for new drugs, particularly cancer drugs, much-needed to combat the ever-growing challenge that currently claims over 10 million lives per year. Eight out of nine drug candidates...